Abbvie initiates new clinical trial to evaluate humira® (adalimumab) for the treatment of fingernail psoriasis
20 March 2014 | By AbbVie
AbbVie announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab)...